RMD today
$238.98+$0.45 (+0.19%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourDescending Triangle
1 hourSymmetric Triangle
15 minBullish
5 minLeaning Bullish
Daily trend turns down below $218.03
Key levels
Resistance$255.56
Resistance$245.65
Support$235.50
Support$221.59
Latest news & SEC filings
AnalystResMed downgraded by Morgans and Ord Minnett
AnalystCanaccord Genuity cuts ResMed rating to Hold from Buy
AnalystCitigroup keeps Neutral rating on ResMed, lifts target to $270
All RMD news →About ResMed
ResMed develops cloud-connected medical devices and software for sleep and breathing health. Its products include CPAP and bilevel therapy devices, ventilators, masks, and accessories used to treat obstructive sleep apnea, COPD, and other respiratory conditions. The company also offers care management software for home medical equipment providers, home health agencies, and senior living facilities. It operates in two segments, Sleep and Breathing Health and Residential Care Software, serving patients, clinicians, and providers worldwide.
Based on the company's 10-K filed Aug 13, 2026.
NYSE · Healthcare
RESMED INC (RMD)
What Is the Price Target for RMD?
SEPT Low Target
$220.00
SEPT Mid Target
$240.00
SEPT High Target
$288.00
Analyst Consensus
$240.00
Is RMD a Buy or Sell Right Now?
Thesis
- •Revenue growing 9.8% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for RMD.
Start Free Trial →Is RMD Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$235.06
73
Moat Score
WIDE
7/9
Piotroski Score
12.2
Altman Z-Score
What Is Smart Money Doing with RMD?
Insider Signal
SELLING
0 buys / 10 sells (90d)
Congress Signal
BUYING
4 buys / 0 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Farrell Michael J. | director officer | Buy | 4,991 | $730K | Oct 7, 2026 |
| Farrell Michael J. | director officer | Sale | 4,991 | $1.1M | Oct 7, 2026 |
| Leong Justin | officer | Buy | 6,461 | - | Aug 14, 2026 |
| Rider Michael J | officer | Buy | 3,230 | - | Aug 14, 2026 |
| Farrell Michael J. | director officer | Buy | 13,547 | - | Aug 14, 2026 |
| Bloomer Aaron | officer | Buy | 9,072 | - | Aug 14, 2026 |
| FARRELL PETER C | director | Sale | 8,000 | $1.8M | Aug 5, 2026 |
| Farrell Michael J. | director officer | Buy | 4,991 | $730K | Jun 8, 2026 |
| Farrell Michael J. | director officer | Sale | 4,991 | $968K | Jun 8, 2026 |
| Rider Michael J | officer | Sale | 268 | $51K | Jun 1, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →RMD Growth Story
Revenue YoY
9.8%
3yr Revenue CAGR
10.2%
EPS Growth YoY
9.67%
FCF Growth YoY
-0.7%
Revenue Trend
STABLE
Dark Pool Trades for RMD
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for RMD, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:50:17 | $240.49 | 4,986 | $$1.2M | BUY |
| 22:41:01 | $238.53 | 9,700 | $$2.3M | BUY |
| 21:28:26 | $238.53 | 2,241 | $$535K | BUY |
| 21:00:19 | $238.53 | 1,463 | $$349K | BUY |
| 21:00:11 | $238.53 | 4,103 | $$979K | BUY |
5 dark pool trades shown · $$5.4M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for RESMED INC (RMD) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (6 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →RMD — frequently asked questions
What is RMD stock price today?
RESMED INC (RMD) is at $238.98, up 0.19% (+$0.45) at the Nov 12, 2026 close.
Why is RMD stock moving today?
Latest RMD news — Nov 4, 2026: ResMed downgraded by Morgans and Ord Minnett · Nov 2, 2026: Canaccord Genuity cuts ResMed rating to Hold from Buy
What is the RMD price target?
The average analyst price target for RMD is $240.00, ranging from $220 to $288, based on 10 analysts. Latest: Citigroup maintains on Oct 30, 2026.
What do analysts rate RMD?
Analyst ratings for RMD: 2 Buy, 22 Hold, 1 Sell — consensus Hold.
Did RMD beat earnings?
RMD last reported on Oct 29, 2026: EPS $2.91 vs $2.69 expected — a beat of 8.2%.
What is RMD's P/E ratio?
RMD trades at a P/E of 20.9 vs a Healthcare average of 18.4.
Does RMD pay a dividend?
Yes. RMD's dividend yield is 0.82%.
How much debt does RMD have?
RESMED INC reported $250M of debt and $1.0B of cash (Sep 30, 2026).
What are RMD support and resistance levels?
Support: $235.50, $221.59, $211.74. Resistance: $245.65, $255.56, $277.67.
What are insiders doing with RMD?
Insider activity: SELLING, 0 buys and 10 sells in the last 90 days.
What is the latest news on RMD?
Nov 4, 2026: ResMed downgraded by Morgans and Ord Minnett · Nov 2, 2026: Canaccord Genuity cuts ResMed rating to Hold from Buy · Oct 30, 2026: Citigroup keeps Neutral rating on ResMed, lifts target to $270